Received: from VI0PR02MB10948.eurprd02.prod.outlook.com (2603:10a6:800:265::10) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Thu, 11 Jun 2026 06:10:34 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com (2603:10a6:150:318::18) by VI0PR02MB10948.eurprd02.prod.outlook.com (2603:10a6:800:265::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.113.11; Thu, 11 Jun 2026 06:10:32 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f]) by GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f%2]) with mapi id 15.21.0092.011; Thu, 11 Jun 2026 06:10:32 +0000 From: "Andrus Varki - RA" To: "Info - SOM" Cc: =?utf-8?Q?Keiu_P=C3=B5derson_-_RA?= References: <0b1142f2de5b4ee9b77a206ee9671966@ravimiamet.ee> In-Reply-To: Subject: =?utf-8?Q?Ed:_Eeln=C3=B5u_edastamine_koosk=C3=B5last?= =?utf-8?Q?amiseks_ja_arvamuse_avaldamiseks?= Date: Thu, 11 Jun 2026 09:10:32 +0300 Keywords: ly Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0021_01DCF984.77007430" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIOkpl4/ke9+WNmGnvinYgaN9pG2wEidV1AAvAO1mEBgZBMcAI+CNbT Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 11 Jun 2026 06:10:32.6258 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: a836e838-71d8-4dc6-2793-08dec78024de X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GVXPR02MB12202:EE_|VI0PR02MB10948:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: a836e838-71d8-4dc6-2793-08dec78024de X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|23010399003|366016|39142699007|31052699007|56012099006|55112099003|8096899003|11063799006|4143699003|22082099003|13003099007|18002099003|41050700001; X-Forefront-Antispam-Report: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GVXPR02MB12202.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(23010399003)(366016)(39142699007)(31052699007)(56012099006)(55112099003)(8096899003)(11063799006)(4143699003)(22082099003)(13003099007)(18002099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 11 Jun 2026 06:10:32.1061 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: a836e838-71d8-4dc6-2793-08dec78024de X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted X-MS-Exchange-Transport-CrossTenantHeadersStamped: VI0PR02MB10948 X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.1366026 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0113.000 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: sYaiMk64Cftm/VG+89qIr6cEuSIqIyLrHCtawT0M0V5C8cQgiX54ufdsubfLeBgEJAuOsMJHFChj8TgAMONd26IYf5v7J74NWDX1Gw2uX6La/pfG016Sz/FQdKU478OMxJoo7AgE+YaoCzR6O2VfLt9vtRf8r/7l/qfA3j1k4hh7gXLi48pS0fjdcE4lqquMl8b6gvUDhaYzgbmhYzy549L5oWj4wmcTEC0TQZhtKNNF6Llen4Telwx3Ck7uPngqd9Nu0cM9C6/xggVGnqgMghy8qooU5ALZM0PIER28Yc3+SFprJANRJ+ROtxP6HKgnT79akvNuJORjvVPp6TVUFt+Ydfuj4DyqP/xNa25u19q1XQdV6FRSd7cT+vCazScx1ZV/xEnEMO45aX/o6i4i1ZUuN9MilFAiaQgPV5P70VdIqmf7FzYAdxC9hirlNe537KHVttDieILZige7QhoJMUXC1eLyma30RLcXUn2yir5N24LSxX+tt9BrTsKH5+VFpbIvLu/FJ5L7zRifQc7xVJ2DC/qK0zomuBMmGz/7bJ/yuCvYh6mrViPC8Tb/vG4frIBMi7HLuhgKzqwrtrC4p8MT79GolTPk6anq7Fjj7BfE/uv+jokDgXYyGkYJOanRvDu1l3qJJHk6oor7D2PzjbX3mbRcY3ecDAj26lH2Wdag2vnAcasL+oXnG/UZmdz1pBBe/ZbqyL6Lj2RnrSlw+J32cDo33LAR57ediWZJmpL3HUrBRA23KLIwS/xl2i3a/7/l5lB53cpHhDM1lXr5gJ1cLixHTuvza4zJKpal8GHGdqiW7IcaHSDPMeWKBpaq Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 x-ms-exchange-organization-originalserveripaddress: 2603:10a6:150:318::18 X-OlkEid: 0000000033F4068251E5764083FB7241D8AC8008070034AD76187591974DBF6C4F76951C873A0100020000000000EE036A86AA193F47AA713E32FE8F2E5700000000120400001F28399546DBFB4BA7B5D21FF91996D0 X-MS-Has-Attach: X-MS-TNEF-Correlator: x-codetwoprocessed: true x-codetwo-clientsignature-inserted: true X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-CrossTenant-MailboxType: HOSTED X-MS-Exchange-CrossTenant-UserPrincipalName: xnTRQcfr3Rc+u0NdjMDiHwzmXBrvd2bAa7AoP3GF8kKAB9TMJcwPAXOTeForSxW/2KF1Ymq+h/960PQlUH+gHMW8MNGrrKhqGNNRlTHEEzg= msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-06-11T06:10:31.798Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; acceptlanguage: et-EE, en-US This is a multipart message in MIME format. ------=_NextPart_000_0021_01DCF984.77007430 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Teie:    03.06.2026 nr 1.2-2/51-1 Meie:   11.06.2026 nr JUR-3/3199-2 Tere Ravimiametil ei ole tähelepanekuid eelnõule. Lugupidamisega Andrus Varki juhataja Õigusosakond Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_0021_01DCF984.77007430 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Teie:=E2=80=82=E2=80=82=E2=80=82=E2=80=8203.06.2026 nr 1.2-2/51-1
Meie:=E2=80=82=E2=80=82=E2=80=8211.06.2026 nr JUR-3/3199-2


Tere

Ravimiametil ei ole t=C3=A4helepanekuid eeln=C3=B5ule. 


Lugupidamisega

Andrus Varki

juhataja

=C3=95igusosakond


Ravimiamet

737 4140

www.ravimiamet.ee


Selles = e-kirjas sisalduv teave (kaasa arvatud manused) on m=C3=B5eldud = ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja = adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt = v=C3=A4ljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. = Juhul, kui Te olete saanud k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, = teavitage sellest koheselt saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 



 

------=_NextPart_000_0021_01DCF984.77007430--